Greenwood Genetic Center
10
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Longitudinal Studies of the Glycoproteinoses
Role: lead
Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort
Role: collaborator
Rett Syndrome Registry
Role: collaborator
Characterization of Angelman Syndrome
Role: collaborator
A Trial of Levodopa in Angelman Syndrome
Role: collaborator
Genetic and Physical Characteristics of Rett Syndrome
Role: collaborator
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Role: collaborator
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome
Role: lead
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Role: collaborator
Dietary Supplements for the Treatment of Angelman Syndrome
Role: collaborator
All 10 trials loaded